产品说明书
Lecirelin
 |
同义名 : | Lecirelin游离态 |
| CAS号 : | 61012-19-9 | |
| 货号 : | A489833 | |
| 分子式 : | C59H84N16O12 | |
| 纯度 : | 99+% | |
| 分子量 : | 1209.398 | |
| MDL号 : | MFCD00882473 | |
| 存储条件： |
粉末 Keep in dark place,Sealed in dry,Store in freezer, under -20°C 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 12 mg/mL(9.92 mM)，配合低频超声，并水浴加热至45℃助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO H2O: 25 mg/mL(20.67 mM)，配合低频超声助溶 |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Lecirelin is a synthetic gonadotropin releasing hormone (GnRH) analogue which commonly used in the treatment of bovine ovarian follicular cysts. The treatment of choice is intramuscular administration of lecirelin. However, the epidural administration of lecirelin promoted the remission of follicular cysts and an improvement of reproductive parameters compared to intramuscular administration[2]. There was a significantly lower LH release after gonadorelin treatment compared to lecirelin at the doses of 25 or 50 μg and the buserelin treatment[3]. The percentage of disappearance of the dominant follicle (84.8% of ovulation and 4.3% of luteinization) after GnRH treatment was high (82% and 100%, for lecirelin at the doses of 25 and 50 μg respectively). Lecirelin, at the doses indicated for the induction of ovulation, is almost equally effective to induce the disappearance of the dominant follicle at Day 6 to 7 of the estrous cycle[3]. Lecirelin modulates the contractility of the bovine ovarian follicular wall; in basal conditions and after the addition of lecirelin, the strips from preovulatory follicles contract significantly more than strips from cysts[4]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
0.83mL 0.17mL 0.08mL |
4.13mL 0.83mL 0.41mL |
8.27mL 1.65mL 0.83mL |
| 参考文献 |
|---|